Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy : an analysis of two randomized, multicenter trials
- Sprache
-
Englisch
- Identifier
-
1167856619
Beteiligte Personen und Organisationen
Sommerer, Claudia
Witzke, Oliver
Lehner, Frank
Arns, Wolfgang
Reinke, Petra
Eisenberger, Ute
Vogt, Bruno
Heller, Katharina
Jacobi, Johannes
Guba, Markus
Stahl, Rolf
Hauser, Ingeborg A.
Kliem, Volker
Wüthrich, Rudolf
Mühlfeld, Anja
Suwelack, Barbara
Dürr, Michael
Paulus, Eva-Maria
Zeier, Martin
Porstner, Martina
Budde, Klemens
Witzke, Oliver
Lehner, Frank
Arns, Wolfgang
Reinke, Petra
Eisenberger, Ute
Vogt, Bruno
Heller, Katharina
Jacobi, Johannes
Guba, Markus
Stahl, Rolf
Hauser, Ingeborg A.
Kliem, Volker
Wüthrich, Rudolf
Mühlfeld, Anja
Suwelack, Barbara
Dürr, Michael
Paulus, Eva-Maria
Zeier, Martin
Porstner, Martina
Budde, Klemens
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:55 MEZ
Beteiligte
- Sommerer, Claudia
- Witzke, Oliver
- Lehner, Frank
- Arns, Wolfgang
- Reinke, Petra
- Eisenberger, Ute
- Vogt, Bruno
- Heller, Katharina
- Jacobi, Johannes
- Guba, Markus
- Stahl, Rolf
- Hauser, Ingeborg A.
- Kliem, Volker
- Wüthrich, Rudolf
- Mühlfeld, Anja
- Suwelack, Barbara
- Dürr, Michael
- Paulus, Eva-Maria
- Zeier, Martin
- Porstner, Martina
- Budde, Klemens
Ähnliche Objekte (12)
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
Repeated kidney re‐transplantation - the Eurotransplant experience: a retrospective multicenter outcome analysis
Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples : A Multicenter Diagnostic Phase III Trial
Status of periodontal health in German patients suffering from chronic kidney disease - data from the GCKD study
Repeated kidney re-transplantation : the Eurotransplant experience: a retrospective multicenter outcome analysis
Repeated kidney re‐transplantation—the Eurotransplant experience: a retrospective multicenter outcome analysis
Common T-Cell-Receptor motifs and features in patients with cytomegalovirus (CMV)-seronegative end-stage renal disease receiving a peptide vaccination against CMV
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
Repeated kidney re‐transplantation - the Eurotransplant experience: a retrospective multicenter outcome analysis
Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples : A Multicenter Diagnostic Phase III Trial
Status of periodontal health in German patients suffering from chronic kidney disease - data from the GCKD study
Repeated kidney re-transplantation : the Eurotransplant experience: a retrospective multicenter outcome analysis
Repeated kidney re‐transplantation—the Eurotransplant experience: a retrospective multicenter outcome analysis
Common T-Cell-Receptor motifs and features in patients with cytomegalovirus (CMV)-seronegative end-stage renal disease receiving a peptide vaccination against CMV
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
Repeated kidney re‐transplantation - the Eurotransplant experience: a retrospective multicenter outcome analysis
Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples : A Multicenter Diagnostic Phase III Trial
Status of periodontal health in German patients suffering from chronic kidney disease - data from the GCKD study
Repeated kidney re-transplantation : the Eurotransplant experience: a retrospective multicenter outcome analysis
Repeated kidney re‐transplantation—the Eurotransplant experience: a retrospective multicenter outcome analysis